Intelligent Relations
Preston by Intelligent Relations
Molika Ashford
Gray shield icon
Is this you?
Claim your profile.

Molika Ashford

Contributing Editor

AS SEEN ON
360Dx

Preston's Summary

Molika Ashford is a Contributing Editor at various publications including Precision Oncology, GenomeWeb, Precision Medicine Quarterly, and 360Dx. She specializes in topics related to precision medicine, oncology, and genomics, focusing on the intersection of these fields to inform and educate her audience. Her work has been featured in prominent industry outlets, highlighting her expertise and contributions to the discourse on advanced medical technologies.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 58 %
Data Driven: 41 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

Not enough data icon

Not enough data

This information evolves through artificial intelligence and human feedback. Improve this profile .

Articles

360Dx

Quest's Haystack Oncology Expects Rich MRD Data in Coming Year, Bolstered by Research Partnerships

By: Molika Ashford

Premium Save for later NEW YORK – Quest Diagnostics-owned liquid biopsy developer Haystack Oncology is expecting in the next year to bring a new wealth of data supporting the ability of its circulating tumor DNA technology for use in minimal/molecular residual disease (MRD) detection across a variety of indications, especially those where its higher sensitivity may give it a boost over other technologies.

© 2026 Intelligent Relations